Primum non nocere, secundum cavere, tertium sanare: lessons on the management of pulmonary hypertension associated with COPD

Shareable abstract

The results of the PERFECT trial do not support the use of inhaled treprostinil in patients with pulmonary hypertension associated with COPD. Further data from well-designed prospective RCTs are needed on the efficacy and safety of PH drugs in PH-COPD.https://bit.ly/3WpP56z